default author photo

Tian Liu

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital

SCHOLARLY PAPERS

2

DOWNLOADS

201

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Efficacy and Safety of Mufemilast in Patients with Behçet's Syndrome: A Phase 2, Double-Blind, Placebo-Controlled Trial

Number of pages: 30 Posted: 10 Mar 2025
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Tongji University, Wenzhou Medical University, Xiamen University, Xuzhou Medical University, Xuzhou Medical University, Peking University - Department of Rheumatology and Clinical Immunology, Government of the People's Republic of China - Beijing Hospital, Sun Yat-sen University (SYSU) - Department of Rheumatology, Sun Yat-sen University (SYSU) - Sun Yat-sen Memorial Hospital, Zhejiang University, Zhejiang University, People's Hospital of Xinjiang Uygur Autonomous Region, Shandong University - Linyi People's Hospital, Zhengzhou University - First Affiliated Hospital, Anhui Provincial Hospital, Fudan University - Zhongshan Hospital, Soochow University, Capital Medical University, Jilin Province People’s Hospital, Jilin Province People’s Hospital, The University of Hong Kong - Shenzhen Hospital, Baotou Medical College - First Affiliated Hospital, Fudan University, Fudan University, Nanjing Medical University - Jiangsu Province Hospital, Jilin University, Pingxiang People's Hospital, Hangzhou Medical College - Zhejiang Provincial People's Hospital, Chengdu Medical College, Ganzhou Hemay Pharmaceutical Co., Ltd, Ganzhou Hemay Pharmaceutical Co., Ltd and Peking University - Department of Rheumatology and Immunology
Downloads 116 (645,052)

Abstract:

Loading...

Phosphodiesterase 4 inhibitor, Behçet's syndrome, Mufemilast, RCT

2.

Mufemilast in Patients with Behcet's Syndrome: A Phase 2, Double-Blind, Placebo-Controlled Trial

Number of pages: 28 Posted: 08 Sep 2025
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Tongji University - Shanghai Tongji Hospital, Wenzhou Medical University, Xiamen University, Xuzhou Medical University, Xuzhou Medical University, Peking University - Department of Rheumatology and Clinical Immunology, Government of the People's Republic of China - Beijing Hospital, Sun Yat-sen University (SYSU) - Department of Rheumatology, Sun Yat-sen University (SYSU) - Sun Yat-sen Memorial Hospital, Zhejiang University, Zhejiang University, The People’s Hospital of Xin Jiang Uygur Autonomous Region - Department of Rheumatology and Immunology, Linyi People's Hospital, Zhengzhou University - Department of Rheumatology, University of Science and Technology of China (USTC), Fudan University, Soochow University, Capital Medical University, Jilin Province People’s Hospital, Jilin Province People’s Hospital, The University of Hong Kong, Baotou Medical College, Fudan University, Fudan University, Nanjing Medical University - Jiangsu Province Hospital, Jilin University (JLU), Hangzhou Medical College - Zhejiang Provincial People’s Hospital, Chengdu Medical College, Ganzhou Hemay Pharmaceutical Co., Ltd, Ganzhou Hemay Pharmaceutical Co., Ltd and Peking University - Department of Rheumatology and Immunology
Downloads 85 (771,553)

Abstract:

Loading...

Behcet desease, phosphodiesterase inhibitor, PDE inhibitor, oral ulcer